全文获取类型
收费全文 | 2345篇 |
免费 | 172篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 66篇 |
妇产科学 | 29篇 |
基础医学 | 297篇 |
口腔科学 | 41篇 |
临床医学 | 209篇 |
内科学 | 657篇 |
皮肤病学 | 50篇 |
神经病学 | 176篇 |
特种医学 | 129篇 |
外科学 | 288篇 |
综合类 | 31篇 |
预防医学 | 159篇 |
眼科学 | 58篇 |
药学 | 211篇 |
中国医学 | 13篇 |
肿瘤学 | 104篇 |
出版年
2023年 | 13篇 |
2022年 | 20篇 |
2021年 | 68篇 |
2020年 | 30篇 |
2019年 | 58篇 |
2018年 | 74篇 |
2017年 | 59篇 |
2016年 | 55篇 |
2015年 | 46篇 |
2014年 | 77篇 |
2013年 | 93篇 |
2012年 | 116篇 |
2011年 | 137篇 |
2010年 | 102篇 |
2009年 | 99篇 |
2008年 | 108篇 |
2007年 | 114篇 |
2006年 | 114篇 |
2005年 | 102篇 |
2004年 | 85篇 |
2003年 | 80篇 |
2002年 | 77篇 |
2001年 | 61篇 |
2000年 | 76篇 |
1999年 | 52篇 |
1998年 | 46篇 |
1997年 | 44篇 |
1996年 | 53篇 |
1995年 | 37篇 |
1994年 | 26篇 |
1993年 | 26篇 |
1992年 | 48篇 |
1991年 | 28篇 |
1990年 | 37篇 |
1989年 | 26篇 |
1988年 | 33篇 |
1987年 | 28篇 |
1986年 | 17篇 |
1985年 | 11篇 |
1984年 | 12篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1975年 | 8篇 |
1974年 | 13篇 |
1973年 | 11篇 |
1972年 | 10篇 |
1971年 | 9篇 |
1970年 | 10篇 |
1969年 | 10篇 |
1966年 | 9篇 |
排序方式: 共有2534条查询结果,搜索用时 30 毫秒
71.
72.
73.
74.
Laura Villarreal‐Martínez Jaime García‐Chvez Berenice Snchez‐Jara Aida Mashenka Moreno‐Gonzlez Janet Soto‐Padilla Efraín Aquino‐Fernndez Rogelio Paredes‐Aguilera Karla Maldonado‐Silva Cecilia Rodríguez‐Castillejos Ana Itamar Gonzlez‐vila María Mora‐Torres Hector Manuel Tiznado‐García Natalia Elizabeth Padilla‐Durn Nuria Citlali Luna‐Silva Eric Israel Gutirrez‐Jurez Jorge Nemi‐Cueto Claudia Sofia Gmez‐Gonzlez Ricardo De Len‐Figueroa Adela Lpez‐Miranda Mirna Guadalupe Ríos‐Osuna Edna Liliana Tamez‐Gmez Elio Aarn Reyes‐Espinoza Irving Armando Domínguez‐Varela Gerardo Gonzlez‐Martínez Elias Adn Godoy‐Salinas 《Haemophilia》2020,26(2):290-297
75.
76.
Kevin M. Pantalone DO Kashif Munir MD Clinton M. Hasenour PhD Charles M. Atisso PhD Oralee J. Varnado PhD Juan M. Maldonado PharmD Manige Konig MD 《Diabetes, obesity & metabolism》2020,22(12):2209-2226
Despite treatment advances leading to improved outcomes over the past 2 decades, cardiovascular (CV) disease (CVD) remains the leading cause of morbidity and mortality in people with diabetes. People with type 2 diabetes (T2D) have a 2- to 4-fold increased risk of CVD and CV death. Individuals with T2D have not seen the same improvements in CV morbidity and mortality as those without T2D. Given this, it is important to understand the CV impact of drugs used to treat T2D. In patients with T2D, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown a reduction in HbA1c and body weight regardless of their differences in chemical structure and pharmacokinetic variables. Glycaemic efficacy, accompanied by the potential for weight reduction and a low risk of hypoglycaemia, has moved GLP-1 RAs to the first treatment of choice following metformin monotherapy in the latest American Diabetes Association treatment guidelines. Additionally, all GLP-1 RAs have shown CV safety and several have proven CV benefit. GLP-1 RAs have been evaluated in cardiovascular outcomes trials (CVOTs) of varying sizes, designs and patient populations with differing reported effects on CV outcomes. The purpose of this article is to review the completed GLP-1 RA CVOTs with special attention to how their design, size, patient populations and conduct may influence the interpretation of results. 相似文献
77.
78.
Silvio Sarubbo Alessandro De Benedictis Igor L. Maldonado Gianpaolo Basso Hugues Duffau 《Brain structure & function》2013,218(1):21-37
The anatomy and functional role of the inferior fronto-occipital fascicle (IFOF) remain poorly known. We accurately analyze its course and the anatomical distribution of its frontal terminations. We propose a classification of the IFOF in different subcomponents. Ten hemispheres (5 left, 5 right) were dissected with Klingler’s technique. In addition to the IFOF dissection, we performed a 4-T diffusion tensor imaging study on a single healthy subject. We identified two layers of IFOF. The first one is superficial and antero-superiorly directed, terminating in the inferior frontal gyrus. The second is deeper and consists of three portions: posterior, middle and anterior. The posterior component terminates in the middle frontal gyrus (MFG) and dorso-lateral prefrontal cortex. The middle component terminates in the MFG and lateral orbito-frontal cortex. The anterior one is directed to the orbito-frontal cortex and frontal pole. In vivo tractography study confirmed these anatomical findings. We suggest that the distribution of IFOF fibers within the frontal lobe corresponds to a fine functional segmentation. IFOF can be considered as a “multi-function” bundle, with each anatomical subcomponent subserving different brain processing. The superficial layer and the posterior component of the deep layer, which connects the occipital extrastriate, temporo-basal and inferior frontal cortices, might subserve semantic processing. The middle component of the deep layer could play a role in a multimodal sensory–motor integration. Finally, the anterior component of the deep layer might be involved in emotional and behavioral aspects. 相似文献
79.
80.
Christine E. Ghatan Jonathan Altamirano Magali Fassiotto Marcelina G. Perez Yvonne Maldonado Shellie Josephs Daniel Y. Sze Nishita Kothary 《Journal of vascular and interventional radiology : JVIR》2019,30(11):1870-1875
PurposeTo examine the impact of targeted efforts to increase the number of female speakers at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (ASM) by reporting gender trends for invited faculty in 2017/2018 vs 2016.Materials and MethodsFaculty rosters for the 2016, 2017, and 2018 SIR ASMs were stratified by gender to quantify female representation at plenary sessions, categorical courses, symposia, self-assessment modules, and “meet-the-expert” sessions. Keynote events, scientific abstract presentations, and award ceremonies were excluded. In 2017, the SIR Annual Meeting Committee issued requirements for coordinators to invite selected women as speakers. Session coordinators are responsible for issuing speaker invitations, and invited speakers have the option to decline.ResultsYears 2017 and 2018 showed increases in female speaker representation, with women delivering 13% (89 of 687) and 14% (85 of 605) of all assigned presentations, compared with 9% in 2016 (46 of 514; P = .03 and P = .01, respectively). Gender diversity correlated with the gender of the session coordinator(s). When averaged over a 3-year period, female speakers constituted 7% of the speaker roster (112 of 1,504 presentations) for sessions led by an all-male coordinator team, compared with 36% (108 of 302) for sessions led by at least 1 female coordinator (P < .0001). Results of the linear regression model confirmed the effect of coordinator team gender composition (P < .0001).ConclusionsHaving a woman as a session coordinator increased female speaker participation, which suggests that the inclusion of more women as coordinators is one mechanism for achieving gender balance at scientific meetings. 相似文献